Philips Once Again Recognized as a Top 100 Global Innovator

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has again been named a Derwent Top 100 Global Innovator by Clarivate Analytics. Clarivate Analytics' Top 100 Global Innovators Report identifies the world's most innovative organizations, assessing each one on its ability to successfully develop valuable patented inventions that also have strong commercialization potential based on originality, market reach, and opportunities for spin-off inventions. Philips has successively won a place on this prestigious list for the last six years.

"I am pleased that Philips has been honored for the 6th consecutive time as a Derwent Top 100 Global Innovator by Clarivate Analytics," said Frans van Houten, CEO of Royal Philips. "This is a much-valued recognition of our ability to create breakthrough innovations aimed to enhance the quality and productivity of healthcare, and improve people's lives."

The Top 100 Global Innovators listed in the report are from three continents and 12 countries/regions. Clarivate Analytics' assessment methodology is based on four principal criteria: overall patent volume, patent application-to-grant success rate, global reach of the portfolio and patent influence as evidenced by citations. This peer-reviewed methodology is executed using Clarivate solutions including Derwent World Patents Index (DWPI) and Derwent Patent Citations Index (DPCI). The index provides editorially enhanced, authoritative and accurate patent data, and is trusted by more than 40 patent offices worldwide.

According to Clarivate Analytics, placement on the list has become a standard measure for innovation across the world and is recognized as a significant achievement for those who are named.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2017 sales of EUR 17.8 billion and employs approximately 77,000 employees with sales and services in more than 100 countries.

Most Popular Now

AI Points the Way to Better Doctor-Patie…

A computer analysis of hundreds of thousands of secure email messages between doctors and patients found that most doctors use language that is too complex for their patients to understand...

Open Call DIGITAL-2021-DEPLOY-01-TWINS-H…

The development of digital twins in healthcare (DTH) has progressed substantially, profiting from advances in science and technology. In order to exploit their benefits in view of better prevention approaches...

Mayo Clinic Researchers Use AI, Biomarke…

Treatment options for rheumatoid arthritis have often relied on trial and error. Now Mayo Clinic researchers are exploring the use of artificial intelligence (AI) and pharmacogenomics to predict how patients...

Mjog by Livi Launches Remote Monitoring …

Mjog by Livi has launched a remote monitoring tool that will help GPs support and monitor people with depression through messages sent to their smartphones. The latest data from the Office...

Could EKGs Help Doctors use AI to Detect…

Pulmonary embolisms are dangerous, lung-clogging blot clots. In a pilot study, scientists at the Icahn School of Medicine at Mount Sinai showed for the first time that artificial intelligence (AI)...

Computer Model of Blood Enzyme

Membrane-associated proteins play a vital role in a variety of cellular processes, yet little is known about the membrane-association mechanism. Lipoprotein-associated phospholipase A2 (Lp-PLA2) is one such protein with an...

4.5 Million Euros in EU Funding for Saar…

This year, three computer scientists from Saarbrücken were awarded an "ERC Starting Grant" by the European Research Council. This award, endowed with 1.5 million euros each, is among the most...

2022 EU4Health Work Programme Adopted to…

Today the Commission has adopted the second EU4Health work programme. In 2022, the EU4Health will continue to invest in building stronger, more resilient health systems and pave the way for...

Five NHS Trusts in Surrey and Sussex to …

A consortium of NHS trusts that covers a population of circa 1.2 million will gain immediate access to important patient imaging, and will mobilise a regional workforce for patients, following...

Helping Cancer Patients Avoid Excessive …

A Case Western Reserve University-led team of scientists has used Artificial Intelligence (AI) to identify which patients with certain head and neck cancers would benefit from reducing the intensity of...

The Programme for the Union's Action in …

On 24 March 2021, Regulation (EU) 2021/522 of the European Parliament and of the Council1 was adopted as part of the Multiannual Financial Framework for the 2021-2027 period. That Regulation...

CliniSys Acquires HORIZON Lab Systems an…

CliniSys is announcing the recent acquisition of HORIZON Lab Systems and the combination with Sunquest Information Systems, as CliniSys. This acquisition and Sunquest combination creates one of the world’s...